VNIM
WST icon

Vaughan Nelson Investment Management’s West Pharmaceutical WST Stock Holding History

Vaughan Nelson Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-56,885
Closed -$8.66M – 204
2020
Q1 		$8.66M Sell
56,885
-675
-1% -$104K 0.15% 152
2019
Q4 		$8.65M Sell
57,560
-1,840
-3% -$268K 0.11% 155
2019
Q3 		$8.42M Sell
59,400
-51,540
-46% -$7.1M 0.11% 153
2019
Q2 		$13.9M Sell
110,940
-30,960
-22% -$3.65M 0.18% 145
2019
Q1 		$15.6M Buy
+141,900
New +$14.8M 0.21% 145

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Vaughan Nelson Investment Management's WST Position: Q2 2020 in Review

Vaughan Nelson Investment Management sold out of West Pharmaceutical (WST) in Q2 2020, closing a stake of 56,885 shares — an estimated $8.66M sold.

Vaughan Nelson Investment Management first reported a position in WST in Q1 2019 and held it in 5 quarters. The position peaked at $15.6M in Q1 2019. 524 funds tracked by Wall St. Rank hold WST as of Q2 2020.

  • Vaughan Nelson Investment Management reported no remaining West Pharmaceutical position as of Q2 2020 after selling out during the quarter.
  • Vaughan Nelson Investment Management sold 56,885 West Pharmaceutical shares in Q2 2020, an estimated $8.66M.
  • Vaughan Nelson Investment Management first reported a position in West Pharmaceutical in Q1 2019 and held it in 5 quarters.
  • Vaughan Nelson Investment Management's West Pharmaceutical position peaked at $15.6M in Q1 2019.
  • 524 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2020.

Based on Vaughan Nelson Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.